Back to search

Switzerland· 68518002

Lenalidomid Devatis 5 mg, Hartkapseln

A lenalidomide product containing lenalidomidum, registered in Switzerland by Devatis AG and dispensed under Swissmedic category A. The same ATC class is registered in 16 of our 19 countries.

Cat A (Swissmedic)ATC L04AX04

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedLenalidomid Devatis 5 mg, HartkapselnATCL04AX04REGISTER NO.68518002PACKS LISTED0CHECKEDSeptember 12, 2026

Where it is registered

Lenalidomide is registered in 16 of 19 countries.

Countries holding a registration under ATC L04AX04 (lenalidomide), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 9 of them publish a price we can compare per daily dose

Lenalidomide · ATC L04AX04

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lenalidomide costs, country by country.

Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.

  • Switzerland: $47.45 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Lenalidomide · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$47.45
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
lenalidomidum
Manufacturer
Devatis AG
Country
Switzerland (CH)
ATC code
L04AX04
ATC class
Lenalidomide
Defined daily dose
10 mg, O
Swissmedic category
A
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

397 interactions on record for lenalidomide.

Graded by severity as the source publishes them — 75 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lenalidomide · interactions on record

397 records

  • 75 severe
  • 105 moderate
  • 1 minor
  • 216 info

Most severe, free to view

  • ErythropoietinB03XA01severe
  • Darbepoetin alfaB03XA02severe
  • PeginesatideB03XA04severe
  • C1-inhibitor, plasma derivedB06AC01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lenalidomide in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lenalidomide products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Lenalidomid +pharma, Lenalidomid Biocon
  • Belgium · Lenalidomid Grindeks, Lenalidomide Eg
  • Bulgaria · Lenalidomide Sandoz, Леналидомид Алкалоид-Инт
  • Cyprus · 7,5 Mg Stada, Lenalidomide Grindeks
  • Czechia · Lenalidomid Sandoz, Lenalidomid Stada
  • Germany · Lenabdor, Lenalidomid 123-Acurae Pharma
  • Denmark · Lenalidomid Grindeks, Lenalidomid Medical Valley
  • Estonia · Lenalidomide Auxilia, Lenalidomide Grindeks
  • Spain · Lenalidomida Aurovitas, Lenalidomida Grindeks
  • Finland · Ferulinor Stada, Lenalidomid Avansor
  • France · Lenalidomide Arrow, Lenalidomide Eg
  • United Kingdom (Northern Ireland) · Lenalidomide, Lenalidomide Amarox
  • Greece · Cortedal, Lenalidomide
  • Croatia · Lenalidomid Alkaloid-Int, Lenalidomid Grindeks
  • Hungary · Lenalidomid Teva, Lenalidomide Grindeks
  • Ireland · Lenalidomide Clonmel, Lenalidomide Grindeks
  • Iceland · Cortedal, Ferulinor
  • Italy · Kleder, Lenalidomide Aurobindo
  • Liechtenstein · Lenalidomide Accord, Lenalidomide Mylan
  • Lithuania · Lenalidomide G.L., Lenalidomide Grindeks
  • Luxembourg · Lenalidomide, Lenalidomide Eg
  • Latvia · Lenalidomide Grindeks, Lenalidomide Norameda
  • Malta · Lenalidomida Generis, Lenalidomide Generis
  • Netherlands · Lenalidomide Alkaloid-Int, Lenalidomide Amarox
  • Norway · Ferulinor, Lenalidomid Medical Valley
  • Poland · Kleder, Lenalidomide Eugia
  • Portugal · Lenalidomida Biocon, Lenalidomida Generis
  • Romania · Lenalidomidă Alkaloid-Int, Lenalidomidă Grindeks
  • Sweden · Ferulinor, Lenalidomid Avansor
  • Slovenia · Lenabdor, Lenalidomid Alkaloid-Int
  • Slovakia · Lenalidomid Glenmark, Lenalidomid Grindeks

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c162c766-2fba-4b65-b9a4-e96eba20ec2d
GET /v1/drugs/c162c766-2fba-4b65-b9a4-e96eba20ec2d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}

See everything about lenalidomide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.